Tuesday, November 02, 2021 10:18:31 AM
Disembarks, mutinies or tries to navigate back even though the point of no return has already been passed. Of course, you can also trust the captain ... all lamenting is futile in the end - a decision is inevitable either way. The present situation reminds me of the story of the discovery of America: "More than a month had passed since the departure from the Canary Islands, and none of those present had ever made a long sea voyage with no land in sight. Columbus cheered up the crews and tried to convince the sailors of the advantages that awaited them on land. Besides, he said, complaints were useless because it was now decided to get to India to find a shorter trade route. Columbus summoned his authoritative companions to get out one last deadline of three days, which he succeeded in doing ..." The rest of the story is known ... a new continent was discovered.
Recent IBIO News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 08:31:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:18:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:15:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:16:28 PM
- iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors • GlobeNewswire Inc. • 05/08/2026 11:15:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/29/2026 01:11:36 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/17/2026 09:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 01:00:47 PM
- iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:31:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:30:09 AM
- iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) • GlobeNewswire Inc. • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:04:38 AM
- iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss • GlobeNewswire Inc. • 03/09/2026 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/09/2026 04:15:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:49:58 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/27/2026 09:23:59 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:19:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/10/2026 09:16:39 PM
- iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/10/2026 09:05:00 PM
